We have reported the presence of an IFN-γ-producing CD3+CD4−CD8−γδ+ T cell population in a large-scale influenza vaccination trial which is unrelated to the study cohort, vaccine group, the gender and ethnicity of subjects, and the ex vivo re-stimulation conditions of their PBMCs. The gene discussed is IFNG; the disease is influenza.